The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study
Chelsea Xu(University of California, San Francisco), Jennifer C. Lai(University of California, San Francisco), Michael A. Dunn(University of Pittsburgh Medical Center), Dorry L. Segev(New York University), Yara Mohamad(University of California, San Francisco), Elizabeth C. Verna(Columbia University Irving Medical Center), Matthew R. Kappus(Duke University), Monica A. Tincopa(University of California San Diego), Daniel Ganger(Northwestern University), Andrés Duarte‐Rojo(Northwestern Medical Faculty Foundation), Joshua D. Grab(University of California, San Francisco), Brian J. Boyarsky(Johns Hopkins University), Robert S. Rahimi(Baylor University), Mara McAdams‐DeMarco(New York University), Michael L. Volk(Loma Linda University), Daniela P. Ladner(Northwestern University)
Cited by 33
Related Papers
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2021|629
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565